Calabretta, R.; Beer, L.; Prosch, H.; Kifjak, D.; Zisser, L.; Binder, P.; Grünert, S.; Langsteger, W.; Li, X.; Hacker, M.
Induction of Arterial Inflammation by Immune Checkpoint Inhibitor Therapy in Lung Cancer Patients as Measured by 2-[18F]FDG Positron Emission Tomography/Computed Tomography Depends on Pre-Existing Vascular Inflammation. Life 2024, 14, 146.
https://doi.org/10.3390/life14010146
AMA Style
Calabretta R, Beer L, Prosch H, Kifjak D, Zisser L, Binder P, Grünert S, Langsteger W, Li X, Hacker M.
Induction of Arterial Inflammation by Immune Checkpoint Inhibitor Therapy in Lung Cancer Patients as Measured by 2-[18F]FDG Positron Emission Tomography/Computed Tomography Depends on Pre-Existing Vascular Inflammation. Life. 2024; 14(1):146.
https://doi.org/10.3390/life14010146
Chicago/Turabian Style
Calabretta, Raffaella, Lucian Beer, Helmut Prosch, Daria Kifjak, Lucia Zisser, Patrick Binder, Stefan Grünert, Werner Langsteger, Xiang Li, and Marcus Hacker.
2024. "Induction of Arterial Inflammation by Immune Checkpoint Inhibitor Therapy in Lung Cancer Patients as Measured by 2-[18F]FDG Positron Emission Tomography/Computed Tomography Depends on Pre-Existing Vascular Inflammation" Life 14, no. 1: 146.
https://doi.org/10.3390/life14010146
APA Style
Calabretta, R., Beer, L., Prosch, H., Kifjak, D., Zisser, L., Binder, P., Grünert, S., Langsteger, W., Li, X., & Hacker, M.
(2024). Induction of Arterial Inflammation by Immune Checkpoint Inhibitor Therapy in Lung Cancer Patients as Measured by 2-[18F]FDG Positron Emission Tomography/Computed Tomography Depends on Pre-Existing Vascular Inflammation. Life, 14(1), 146.
https://doi.org/10.3390/life14010146
